Ashok Vellodi

7.5k total citations
105 papers, 4.9k citations indexed

About

Ashok Vellodi is a scholar working on Physiology, Cell Biology and Epidemiology. According to data from OpenAlex, Ashok Vellodi has authored 105 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Physiology, 33 papers in Cell Biology and 26 papers in Epidemiology. Recurrent topics in Ashok Vellodi's work include Lysosomal Storage Disorders Research (83 papers), Cellular transport and secretion (32 papers) and Trypanosoma species research and implications (22 papers). Ashok Vellodi is often cited by papers focused on Lysosomal Storage Disorders Research (83 papers), Cellular transport and secretion (32 papers) and Trypanosoma species research and implications (22 papers). Ashok Vellodi collaborates with scholars based in United Kingdom, United States and Germany. Ashok Vellodi's co-authors include Bryan Winchester, E. Young, Anna Tylki‐Szymańska, J. E. Wraith, Elisabeth Young, Eugen Mengel, Uma Ramaswami, Roberto Giugliani, Alan Cooper and Michael Beck and has published in prestigious journals such as Blood, Neurology and PEDIATRICS.

In The Last Decade

Ashok Vellodi

104 papers receiving 4.7k citations

Peers

Countries citing papers authored by Ashok Vellodi

Since Specialization

Citations

This map shows the geographic impact of Ashok Vellodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok Vellodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok Vellodi more than expected).

Fields of papers citing papers by Ashok Vellodi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashok Vellodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok Vellodi. The network helps show where Ashok Vellodi may publish in the future.

Co-authorship network of co-authors of Ashok Vellodi

This figure shows the co-authorship network connecting the top 25 collaborators of Ashok Vellodi. A scholar is included among the top collaborators of Ashok Vellodi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashok Vellodi. Ashok Vellodi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease 2022 ·Orphanet Journal of Rare Diseases ·Aimée Donald, (unknown), Ashok Vellodi, Timothy M. Cox, Derralynn Hughes, Simon Jones, Robert Wynn, Maciej Machaczka	16
2	Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry 2016 ·Molecular Genetics and Metabolism ·Amal El‐Beshlawy, Anna Tylki‐Szymańska, Ashok Vellodi, Nadia Belmatoug, Gregory A. Grabowski, Edwin H. Kolodny, Julie L. Batista, Gerald F. Cox, Pramod K. Mistry	41
3	Successful Desensitisation in a Patient with CRIM-Positive Infantile-Onset Pompe Disease 2013 ·JIMD Reports ·Julien Baruteau, Alexander Broomfield, (unknown), (unknown), K Harvey, Derek Burke, Michael Burch, G Shepherd, Ashok Vellodi	19
4	Idursulfase treatment of Hunter syndrome in children younger than 6 years: Results from the Hunter Outcome Survey 2011 ·Genetics in Medicine ·Joseph Muenzer, Michael Beck, Roberto Giugliani, Yasuyuki Suzuki, Anna Tylki‐Szymańska, Vassili Valayannopoulos, Ashok Vellodi, J. E. Wraith	77
5	Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure 2011 ·Orphanet Journal of Rare Diseases ·Minke H. de Ru, Jaap Jan Boelens, Anibh M. Das, Simon Jones, Johanna H. van der Lee, Nizar Mahlaoui, Eugen Mengel, Martin Offringa, Anne O’Meara, Rossella Parini, Attilio Rovelli, Karl‐Walter Sykora, Vassili Valayannopoulos, Ashok Vellodi, Robert Wynn, Frits A. Wijburg	177
6	Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis 2009 ·British Journal of Haematology ·Pramod K. Mistry, Patrick Deegan, Ashok Vellodi, J. Alexander Cole, (unknown), Neal J. Weinreb	90
7	Splenic nodules in paediatric Gaucher disease treated by enzyme replacement therapy 2008 ·Pediatric Radiology ·(unknown), Kieran McHugh, Ashok Vellodi	7
8	Randomized, controlled trial of miglustat in Gaucher's disease type 3 2008 ·Annals of Neurology ·Raphael Schiffmann, Edmond J. FitzGibbon, Chris Harris, Catherine DeVile, Elin Haf Davies, Larry A. Abel, Ivo N. van Schaik, William Benko, Margaret Timmons, Markus Ries, Ashok Vellodi	177
9	Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease 2007 ·Skeletal Radiology ·Mario Maas, T. N. Hangartner, Giuliano Mariani, Kieran McHugh, Sally Moore, Gregory A. Grabowski, Paige Kaplan, Ashok Vellodi, John Yee, Lynne S. Steinbach	41
10	A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) 2006 ·Genetics in Medicine ·Joseph Muenzer, J. E. Wraith, Michael Beck, Roberto Giugliani, Paul Harmatz, Christine M. Eng, Ashok Vellodi, Rick Martin, Uma Ramaswami, Müge Güçsavaş‐Çalıkoğlu, Suresh Vijayaraghavan, S. Wendt, (unknown), (unknown), Marwan Shinawi, Maureen Cleary, (unknown), (unknown), Alan Kimura	457
11	Bone marrow transplantation for lysosomal storage disorders 2006 ·Expert Review of Endocrinology & Metabolism ·Ashok Vellodi	2
12	Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB) 2005 ·Journal of Inherited Metabolic Disease ·Clare Beesley, Marie Jackson, Elisabeth Young, Ashok Vellodi, Bryan Winchester	35
13	Lysosomal storage disorders 2005 ·British Journal of Haematology ·Ashok Vellodi	207
14	Monitoring the clinical and biochemical response to enzyme replacement therapy in three children with Fabry disease 2004 ·European Journal of Pediatrics ·Kevin Mills, Ashok Vellodi, Peter J. Morris, Donald P. Cooper, Michael Morris, Elisabeth Young, Bryan Winchester	29
15	Mesenteric mass in a young girl – an unusual site for Gaucher's disease 2002 ·Pediatric Radiology ·Adrian Lim, Ashok Vellodi, Kieran McHugh	22
16	Disordered breathing during sleep in patients with mucopolysaccharidoses 2001 ·International Journal of Pediatric Otorhinolaryngology ·S. E. J. Leighton, B.C. Papsin, Ashok Vellodi, R Dinwiddie, R Lane	83
17	Ocular Motor Abnormalities in Gaucher Disease 1999 ·Neuropediatrics ·Christopher M. Harris, David S. Taylor, Ashok Vellodi	44
18	Carpal tunnel syndrome in the mucopolysaccharidoses and mucolipidoses 1997 ·Journal of Bone and Joint Surgery - British Volume ·Fares S. Haddad, David H. Jones, Ashok Vellodi, Nicholas Kane, Matthew Pitt	76
19	Anaesthesia and the lipidoses: a review of patients treated by bone marrow transplantation 1992 ·Pediatric Anesthesia ·(unknown), N. Soni, Ashok Vellodi	9
20	Hemiplegia and Focal Convulsions as a Manifestation of Cyclosporine A Toxicity 1987 ·The Journal of Clinical Pharmacology ·Ashok Vellodi, (unknown), K. Hugh‐Jones	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact